Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VEGF Trap versus placebo for recurrent symptomatic malignant ascites in advanced ovarian cancer
2005-005026-31Phase 2Completed
- Sponsor
- Sanofi
- Start
- Mar 2006
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ovarian cancer comparing aflibercept with placebo (2 arms). Started Mar 2006; status: completed.
02
Drugs
aflibercept
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on 2005-005026-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005026-31.